Baricitinib Shown to Improve Moderate to Severe Rheumatoid Arthritis
December 10th 2014Eli Lilly and Company and Incyte Corporation's study of the investigational medicine baricitinib met its primary endpoint of improved American College of Rheumatology scores, ACR20, after 12 weeks of treatment for moderate to severe rheumatoid arthritis, according to a press release.
Read More
Pharmacist Shoots, Injures Robber Wielding Realistic-Looking Gun
December 9th 2014When a would-be robber entered a pharmacy in Wyoming with what looked like a real gun, a pharmacist behind the counter reached for his firearm and injured the suspect by shooting him, according to the Wyoming Tribune Eagle.
Read More
NovoEight Shown to Reduce Annualized Bleeding Rate Among Patients with Hemophilia A
December 9th 2014Novo Nordisk announced that its phase 3 study of patients with hemophilia A, who had the highest annualized bleeding rates in its previous study, saw the biggest reduction in bleeding over the duration of treatment using turoctocog alfa.
Read More
Mild Coronary Artery Disease Puts Diabetics at Cardiovascular Risk
December 8th 2014New study results dispute the belief that diabetic patients with mild or non-obstructive coronary artery disease have a lower risk of major adverse cardiovascular events and death than their counterparts with obstructive disease.
Read More
Scientists Learn More About the Brain by Studying Harry Potter Readers
December 2nd 2014Chapter 9 of Harry Potter and the Sorcerer's Stone not only hinted at the young wizard's promising future as a Quidditch player, but also helped scientists detect the different brain regions activated among story readers.
Read More
Zohydro ER Deemed Safe, Effective as Long-Term Chronic Pain Treatment
December 2nd 2014A late-stage trial of extended-release hydrocodone bitartrate (Zohydro ER) pointed to a generally safe and well-tolerated response among patients with chronic pain for up to 1 year, according to Zogenix, Inc.
Read More